Government Regulation of Drug Pricing and the Evolving Pharmaceutical Supply Chain

By Theresa C. Carnegie

Theresa Carnegie discusses both federal and state activity regarding the regulation of drug pricing and how new entrants to the market, among other factors, are changing traditional pharmaceutical supply chain industry paradigms.

Subscribe To Viewpoints

Published

    • Viewpoint Topics

  • Health Care

    • Professionals

  • Theresa C. Carnegie

    • Related Industries

  • PBMs & Pharmacies

    • Author

    Theresa C. Carnegie

    Theresa C. Carnegie

    Member

    Theresa advises clients on all aspects of the pharmaceutical supply chain, including counseling industry stakeholders on a range of business, legal, transactional, and compliance matters. She provides clients with strategic counseling and creative business modeling that considers legal restrictions and regulatory risk in light of innovation and business goals.